Skip to main content
Top
Published in: Clinical and Experimental Nephrology 6/2013

01-12-2013 | Images in Nephrology

Pleural effusion in peritoneal dialysis: overload or leakage?

Authors: Eleonora Riccio, Gennaro Argentino, Antonio Pisani, Bruno Memoli

Published in: Clinical and Experimental Nephrology | Issue 6/2013

Login to get access

Excerpt

A 68-year-old female treated by peritoneal dialysis (PD) for 4 years was hospitalized for cough and dyspnea without chest pain. Chest X-ray revealed massive right pleural effusion. High glucose content in pleural fluid in comparison with blood glucose level was suggestive of transdiaphragmatic leakage. To establish the communication between the peritoneal and pleural cavity, peritoneal scintigraphy was performed. Different 99mTc-labeled colloids have been used for peritoneal scintigraphy in the past years, such as sulfur colloid, macroaggregated albumin, and diethylenetriamine pentaacetic acid (DTPA), each with some important limitations. On the basis of the characteristics of icodextrin, an osmotic colloid agent routinely used in PD, such as its persistence in the peritoneal space, 99mTc-icodextrin scintigraphy was performed to confirm the diagnosis of peritoneopleural leakage (Fig. 1a, b). Therefore, 99mTc-icodextrin scintigraphy may represent a new, simple, noninvasive, cost-effective, well-tolerated, and safe radionuclide imaging method to clearly detect some causes of peritoneal dialysis failure.
Metadata
Title
Pleural effusion in peritoneal dialysis: overload or leakage?
Authors
Eleonora Riccio
Gennaro Argentino
Antonio Pisani
Bruno Memoli
Publication date
01-12-2013
Publisher
Springer Japan
Published in
Clinical and Experimental Nephrology / Issue 6/2013
Print ISSN: 1342-1751
Electronic ISSN: 1437-7799
DOI
https://doi.org/10.1007/s10157-013-0794-8

Other articles of this Issue 6/2013

Clinical and Experimental Nephrology 6/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.